Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of ...

The price of semaglutide drugs could drop by more than 65% when generic versions of Ozempic and Wegovy hit shelves — possibly ...

The ​Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.

The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...

This article was produced in partnership with The New York Times. Not all drug prices are going up. Amid the public fury over the escalating costs of brand-name medications, the prices of generic ...

The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...

Officials with the FDA have approved the first generic robenacoxib tablets for the control of postoperative pain and ...